18 July 2022: Articles
Trust the Process: Prolonged Parasitemia in an Elderly Man with Asplenia from the American Midwest
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Educational Purpose (only if useful for a systematic review or synthesis)
Marko Ivancich D* , Larry Lutwick A , F.N.U. Shweta ADOI: 10.12659/AJCR.936326
Am J Case Rep 2022; 23:e936326
Table 1. Laboratory values. Chronological order of relevant laboratory tests performed throughout the patient’s treatment course.
| Lab parameter | Range | Day 0 | Day +1 | Week +1 | Week +4 | Week +6 | Week +9 | Week +18 |
|---|---|---|---|---|---|---|---|---|
| White blood cell count | 3.4–9.6×10/L | 13.9 | 16.3 | 9.1 | 9.5 | 7.6 | 6.5 | 6.6 |
| Hemoglobin | 13.2–16.6 g/dL | 12.2 | 9.9 | 8.4 | 10.9 | 11 | 11.8 | 11.6 |
| Hematocrit | 38.3–48.6% | 33.8 | 27.7 | 25.4 | 34 | 33.5 | 36.3 | 34.4 |
| Total erythrocyte count | 4.35–5.65×10/L | 3.51 | 2.91 | 2.54 | 3.1 | 2.97 | 3.25 | 3.25 |
| Platelet count | 135–317×10/L | 94 | 99 | 109 | 135 | 107 | 138 | 143 |
| Serum creatinine | 0.74–1.35 mg/dL | 1.14 | 1.7 | 0.8 | 0.98 | 0.9 | 0.86 | 0.96 |
| Aspartate aminotransferase | 8–48 U/L | 264 | 270 | 46 | 51 | 36 | ||
| Alanine aminotransferase | 7–55 U/L | 67 | 67 | 50 | 43 | 34 | 28 | 19 |
| Alkaline phosphatase | 40–129 U/L | 92 | 67 | 91 | 90 | |||
| Bilirubin, total | ≤1.2 mg/dL | 2 | 1.4 | 0.9 | 0.5 | |||
| Bilirubin, direct | 0.0–0.3 mg/dL | 0.5 | 0.4 | |||||
| C-reactive protein | ≤8.0 mg/L | 67.4 | 126.9 | 9.8 | 4.5 | |||
| Day 0 – date of first presentation, * values outside normal range for performing laboratory. | ||||||||